Skip to content 
What does 80 mg on a KLOW vial mean?
80 mg is the total listed content of the vial, not a daily dose. The formula examined here contains 50 mg GHK-Cu and 10 mg each of BPC-157, TB-500 and KPV: 50 + 10 + 10 + 10 = 80 mg.1 The KLOW ingredient guide explains those ingredients and their proportions.
What do mg, mcg and mg/mL mean?
Milligrams and micrograms measure mass: 1 mg equals 1,000 micrograms (mcg or µg). Milligrams per milliliter (mg/mL) measure concentration—the amount of material in a given volume of liquid. A number needs both its unit and the name of what it measures.
| Label term | Meaning |
|---|---|
| Vial content: 80 mg | The sum of the four listed ingredient amounts in the container. |
| Component amount: 10 mg KPV | The stated amount of KPV within that total, not an additional 10 mg. |
| Concentration: mg/mL | Mass per milliliter of final liquid. The vial total alone does not provide this value. |
| Dose and schedule | The amount for a particular administration and how often it is given. Neither follows from the vial label. |
| Purity: % | An analytical result with its own reporting basis. It is separate from vial mass and concentration. |
Purity and measured peptide content answer different questions.2 The KLOW COA example shows how to read the test results alongside the label.
Is there an established KLOW peptide dose per day?
The cited studies do not establish a daily dose for the four-component KLOW blend. They investigate different preparations and goals. A dosage chart based on one ingredient would therefore need evidence for the complete blend before it could be treated as a tested KLOW schedule.34
What do the ingredient studies tell us?
In the 2021 knee-pain report, 14 of 16 people contacted reported improvement after BPC-157 alone or with thymosin beta-4. That is an encouraging symptom report, but the small study had no control group and did not test KLOW.3
The copper-tripeptide skin trial studied a topical regimen after laser resurfacing. Among 13 participants who completed it, patient satisfaction was higher with the copper-peptide regimen, while objective skin ratings did not differ significantly.4 Its formulation and setting differ from the knee study and from a KLOW vial.
The KLOW research article compares these studies and their results. For what they suggest about recovery, skin and gut health, see KLOW peptide benefits.
Sources
Wording reviewed September 11, 2026. This article explains label units and the context needed to interpret dosage claims, using selected ingredient studies.
- Pure Lab Peptides, KLOW 80 mg product listing. Formula and commercial record checked September 9, 2026.
- McCarthy D, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. 2023;40(6):1317–1328. doi:10.1007/s11095-023-03493-1.
- Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Alternative Therapies in Health and Medicine. 2021;27(4):8–13.
- Miller TR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Archives of Facial Plastic Surgery. 2006;8(4):252–259.